Skip to content
  • Categories
  • Recent
  • Tags
  • Popular
  • Users
  • Groups
Skins
  • Light
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Collapse
Brand Logo

Forum

  1. Home
  2. PAAB Q&A
  3. Miscellaneous
  4. Product Monograph situation
PAAB Notice
The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB), including but not limited to those available through the PAAB Forum, the PAAB website, and any PAAB correspondences, are specifically intended to assist individuals navigating the PAAB preclearance system. Repurposing or reproducing this content without written consent from the PAAB Commissioner is strictly prohibited. This prohibition includes, but is not limited to, use in machine learning or AI models.

Product Monograph situation

Scheduled Pinned Locked Moved Miscellaneous
2 Posts 2 Posters 360 Views
  • Oldest to Newest
  • Newest to Oldest
  • Most Votes
Reply
  • Reply as topic
Log in to reply
This topic has been deleted. Only users with topic management privileges can see it.
  • L Offline
    L Offline
    Lags
    wrote on last edited by
    #1

    We would like to get your thoughts on a potential situation and how it could affect marketing communication tools.

    Product A: no existing indication, completely new to the market. Product B: Has an NOC for indication X.

    Scenario: Single-use of Product A combined with ongoing or longer use of Product B is granted NOC for indication Z (i.e. PM for Product A) ahead of Product B receiving an additional indication for Z (PM for product B). Note that both products are undergoing Health Canada review for indication Z with the exact same data/ studies. The timing, however, may not be simultaneous.

    Questions: (1) Can the logos of Product A and B be used on promotional pieces? (2) Can we callout the dosing of Product B explicitly? (3) Can information on Product A and B have equal prominence within pieces? (4) Given that product B already has an indication, an HCP and patient website already exists, can we send HCP/patients to Product B’s website (in a specific location) to get information on indication Z? (5) What are key considerations with respect to promotion?

    Thank you.

    Yin ManY 1 Reply Last reply
    0
    • L Lags

      We would like to get your thoughts on a potential situation and how it could affect marketing communication tools.

      Product A: no existing indication, completely new to the market. Product B: Has an NOC for indication X.

      Scenario: Single-use of Product A combined with ongoing or longer use of Product B is granted NOC for indication Z (i.e. PM for Product A) ahead of Product B receiving an additional indication for Z (PM for product B). Note that both products are undergoing Health Canada review for indication Z with the exact same data/ studies. The timing, however, may not be simultaneous.

      Questions: (1) Can the logos of Product A and B be used on promotional pieces? (2) Can we callout the dosing of Product B explicitly? (3) Can information on Product A and B have equal prominence within pieces? (4) Given that product B already has an indication, an HCP and patient website already exists, can we send HCP/patients to Product B’s website (in a specific location) to get information on indication Z? (5) What are key considerations with respect to promotion?

      Thank you.

      Yin ManY Offline
      Yin ManY Offline
      Yin Man
      wrote on last edited by Patrick Massad
      #2

      Hi @lags

      Thank you for your question. There are many factors that will affect the direction and use of both product logos in APS. This forum is not intended to address the specific and complex scenario that has been described. We suggest a consult meeting be arranged with PAAB to fully disclose the nature of the promotion and the content in the respective product monographs. We are unable to provide guidance without further information. Consult meetings may be arranged through our administrative team at review@paab.ca

      1 Reply Last reply
      0
      Reply
      • Reply as topic
      Log in to reply
      • Oldest to Newest
      • Newest to Oldest
      • Most Votes


      • Login

      • Don't have an account? Register

      • Login or register to search.
      • First post
        Last post
      0
      • Categories
      • Recent
      • Tags
      • Popular
      • Users
      • Groups